SPY337.73+0.29 0.09%
DIA279.40-0.64 -0.23%
IXIC11,105.87+93.64 0.85%

Prevail Therapeutics Reports Was Granted Composition Of Matter Patent For Experimental Gene Therapy Program PR006

Benzinga · -